Story · Medicine & Biotech

Ensartinib in ALK-Positive Non–Small-Cell Lung Cancer

1 outlet · first reported by NEJM 15d ago

Coverage, in order

  1. 15d ago
    NEJM indie study peer-reviewed
    Ensartinib in ALK-Positive Non–Small-Cell Lung Cancer

    New England Journal of Medicine, Volume 395, Issue 17 , Page 1767-1768, October 29, 2026.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.